(Total Views: 168)
Posted On: 07/02/2023 10:16:22 AM
Post# of 122
Undervalued NASDAQ Stocks Poised for Growth – $INBS
https://thestreetreports.com/undervalued-nasd...rmed-kavl/
The ultimate aim of any investors is to find value in the market so that they can make significant profits in the long term. There are many stocks in the market that may be undervalued since the wider market may not have realized the potential of those companies. Hence, those stocks present a major opportunity to investors. Here is a quick look at some NASDAQ-listed undervalued stocks that could be on the verge of growth.
Intelligent Bio Solutions Inc (NASDAQ: INBS) – The medical technology company is involved in the delivery of intelligent non-invasive and fast-testing solutions. It was in the news on June 28 after it announced that it had received guidance from the United States Food and Drug Administration about the regulatory classification of its Intelligent Fingerprinting Drug Screening Cartridge.
The agency had provisionally decided that the product fell into the 21 CFR 862.3650, Opiate Test System, which made it a Class II device that necessitated the pre-market notification of 501 (K) and clearance from the FDA before marketing.
https://thestreetreports.com/undervalued-nasd...rmed-kavl/
The ultimate aim of any investors is to find value in the market so that they can make significant profits in the long term. There are many stocks in the market that may be undervalued since the wider market may not have realized the potential of those companies. Hence, those stocks present a major opportunity to investors. Here is a quick look at some NASDAQ-listed undervalued stocks that could be on the verge of growth.
Intelligent Bio Solutions Inc (NASDAQ: INBS) – The medical technology company is involved in the delivery of intelligent non-invasive and fast-testing solutions. It was in the news on June 28 after it announced that it had received guidance from the United States Food and Drug Administration about the regulatory classification of its Intelligent Fingerprinting Drug Screening Cartridge.
The agency had provisionally decided that the product fell into the 21 CFR 862.3650, Opiate Test System, which made it a Class II device that necessitated the pre-market notification of 501 (K) and clearance from the FDA before marketing.
(0)
(0)
